I pick up from David Seymour's comments before around that regulatory complexity. I think I would agree with that in regards to the fact that throughout COVID—and having been a member of the Health Committee throughout that period—I think one of my memories will be around the fact of the challenges around our system in terms of being able to balance the need for the regulatory impact, which is articulated, highlighted, and amplified, in a bill such as this, but also the need to be agile to the rapidly changing environment. I think our regulatory complexity that we do have is an area that does need to be reviewed and simplified. The reality is, as has been canvassed, regulatory complexity and burden does bring a cost, not only a fiscal cost but also a cost in terms of decision making and delay, which can and does have implications more broadly. 